Patient‐Reported Adherence to Guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Abstract

Compliance with JNC VI guidelines decreased over time, and patient adherence to drug therapy was suboptimal. Continuing-education efforts to reinforce optimal blood pressure management are necessary.

Not Getting to Goal: The Clinical Costs of Noncompliance

“…One study demonstrated that compliance was greatest and declined less rapidly among patients with copays from $0 to < $10 compared with patients with copays from $10 to < $20. 18 In this analysis, researchers reported that compliance was lowest and declined most rapidly among patients with copays ≥ $20.…”

Academy of Managed Care Pharmacy

“…33 Overall, the DPP-4 inhibitors were slightly less effective than other hypoglycemic agents. Patients receiving sitagliptin were also more likely to achieve an A1C < 7% compared with those receiving placebo.…”

“…33 Therefore, our examination of total health care costs for only 12 months following diagnosis of UC may not predict longer-term costs, and studies beyond 12 months are needed. Fifth, the cost analysis was based on the amount paid and, therefore, excludes member costs and indirect costs.…”

“…33 Based on pooled analysis of the data from placebo-controlled trials, there was a significant reduction in A1C with exenatide therapy (-0.97%; 95% CI, -1.13% to -0.81%). Patients receiving exenatide were also more likely to achieve an A1C < 7% compared with those receiving placebo.…”

“…31,32 A prospective study examining adherence to the Joint National Committee on Hypertension (JNC VI) treatment guidelines in the New York metropolitan area demonstrated that only 37% of the 821 patients surveyed reported consistent adherence to their anti-hypertensive regimen. 33 In a 1982 study of a cross-sectional sample of 800 adults in Detroit, Michigan, 21% of the 206 hypertensive patients interviewed had stopped drug treatment without being instructed to do so. 34 Patient perception of health status was the most common factor found to distinguish dropouts from those adherent to their medication regimens; poorer perceived health was associated with higher rates of adherence to the prescribed treatment regimen.…”